Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadas Pahima

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical and Experimental Immunology|May 17, 2021
A novel mast cell-dependent allergic peritonitis modelHadas Pahima, Pier Giorgio Puzzovio, Francesca Levi-Schaffer
Clinical Immunology (Orlando, Fla.)|October 27, 2018
2B4 and CD48: A powerful couple of the immune systemHadas Pahima, Pier Giorgio Puzzovio, Francesca Levi-Schaffer
Biochimica Et Biophysica Acta|April 2, 2013
The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosisNurit Keinan, Hadas Pahima, Danya Ben-Hail, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 24, 2021
Update on Eosinophil Interaction with Mast Cells: The Allergic Effector UnitRoopesh Singh Gangwar, Hadas Pahima, Pier Giorgio Puzzovio, et al.
Immunological Reviews|February 13, 2018
Human eosinophils and mast cells: Birds of a feather flock togetherPiper A Robida, Pier Giorgio Puzzovio, Hadas Pahima, et al.
The Journal of Investigative Dermatology|June 17, 2018
A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic KeratosesVered Behar, Hadas Pahima, Adi Kozminsky-Atias, et al.
Pharmacological Research|March 12, 2022
Cromolyn Sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammationPier Giorgio Puzzovio, Thayse R Brüggemann, Hadas Pahima, et al.
Pharmacological Research|February 11, 2023
Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1Pier Giorgio Puzzovio, Hadas Pahima, Tresa George, et al.
Pharmacological Research|May 8, 2020
Granulocyte-targeted therapies for airway diseasesLuciana P Tavares, Hong Yong Peh, Wan Shun Daniel Tan, et al.
Expert Opinion on Investigational Drugs|September 25, 2019
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthmaGiancarlo Marone, Giuseppe Spadaro, Mariantonia Braile, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Immunology|May 17, 2021
A novel mast cell-dependent allergic peritonitis modelHadas Pahima, Pier Giorgio Puzzovio, Francesca Levi-Schaffer
Clinical Immunology (Orlando, Fla.)|October 27, 2018
2B4 and CD48: A powerful couple of the immune systemHadas Pahima, Pier Giorgio Puzzovio, Francesca Levi-Schaffer
Biochimica Et Biophysica Acta|April 2, 2013
The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosisNurit Keinan, Hadas Pahima, Danya Ben-Hail, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 24, 2021
Update on Eosinophil Interaction with Mast Cells: The Allergic Effector UnitRoopesh Singh Gangwar, Hadas Pahima, Pier Giorgio Puzzovio, et al.
Immunological Reviews|February 13, 2018
Human eosinophils and mast cells: Birds of a feather flock togetherPiper A Robida, Pier Giorgio Puzzovio, Hadas Pahima, et al.
The Journal of Investigative Dermatology|June 17, 2018
A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic KeratosesVered Behar, Hadas Pahima, Adi Kozminsky-Atias, et al.
Pharmacological Research|March 12, 2022
Cromolyn Sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammationPier Giorgio Puzzovio, Thayse R Brüggemann, Hadas Pahima, et al.
Pharmacological Research|February 11, 2023
Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1Pier Giorgio Puzzovio, Hadas Pahima, Tresa George, et al.
Pharmacological Research|May 8, 2020
Granulocyte-targeted therapies for airway diseasesLuciana P Tavares, Hong Yong Peh, Wan Shun Daniel Tan, et al.
Expert Opinion on Investigational Drugs|September 25, 2019
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthmaGiancarlo Marone, Giuseppe Spadaro, Mariantonia Braile, et al.
Pageof 2